IRADIMED CORPORATION Announces Fourth Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Iradimed Corp. (IRMD) Tops Q4 EPS by 12c; Guides Above
February 4, 2022 7:03 AM ESTIradimed Corp. (NASDAQ: IRMD) reported Q4 EPS of $0.33, $0.12 better than the analyst estimate of $0.21. Revenue for the quarter came in at $11.9 million versus the consensus estimate of $11.63 million.
GUIDANCE:
Iradimed Corp. sees Q1 2022 EPS of $0.20-$0.21. Iradimed Corp. sees Q1 2022... More
